Media Library

Cells are the basic building blocks of all living things, and genes can be found deep within cells. Genes are small sections of DNA that carry genetic information and instructions for making proteins, which help build and maintain the body.

At Novartis, we are reimagining medicine to produce breakthroughs and address major unmet needs for patients with devastating diseases, including genetic disorders and certain deadly cancers. These efforts are done in collaboration with scientists, physicians, academia, industry partners, and patients.

Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life

The Sickle Cell World Assessment Survey (SWAY) uncovers the impact this disease has on patients and their families.

Cancer 2030: A growing global crisis. This infographic shows the projected cancer cases by region.

A young malaria patient being given a dose of pediatric antimalarial medicine at the AMREF Clinic in the Kibera area of Nairobi, Kenya.

Worldwide distribution center for the Novartis antimalarial in Basel, Switzerland: an employee checks a shipment headed for Mozambique for the US Presidential Malaria Initiative.

A cancer patient's frozen T-Cells arrive at a Novartis facility to be reengineered.

SMS for Life training session teaching healthcare workers how to use text messaging to monitor stock levels of life-saving antimalarials. In Kenya, Machacos district, SMS for Life also includes patient surveillance data on the testing of malaria patients and the use of artemisinin-based combination therapies (ACTs).

SMS for Life is an innovative public-private partnership led by Novartis under the umbrella of the Roll Back Malaria Partnership. The program has been rolled out across Tanzania and pilots are taking place in Ghana and Kenya.

The Frozen T-Cells of a cancer patient.